Regenesome Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $136K

  • Investors
  • 2

Regenesome General Information

Description

Developer of anti-ageing technology intended to develop supplements, foods and cosmetics that utilize exosomes. The company specializes in developing healthcare products that utilize exosome analysis technology and advancing medical field technology, enabling clients to help solve the challenges of aging and advance longevity through biotechnology.

Contact Information

Website
regenesome.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2-21-1 Takanawa
  • TAKANAWA GATEWAY Link Scholars' Hub 6th Floor (LiSH)
  • Tokyo, Minato 108-0074
  • Japan
Primary Industry
Other Healthcare Technology Systems
Other Industries
Personal Products
Vertical(s)
Life Sciences
Corporate Office
  • 2-21-1 Takanawa
  • TAKANAWA GATEWAY Link Scholars' Hub 6th Floor (LiSH)
  • Tokyo, Minato 108-0074
  • Japan

Regenesome Timeline

20252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Regenesome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 18-Sep-2025 $136K Completed Generating Revenue
2. Debt - General 01-May-2025 Completed Generating Revenue
1. Corporate 21-Oct-2024 $546K Completed Generating Revenue
To view Regenesome’s complete valuation and funding history, request access »

Regenesome Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Leave a Nest Capital Venture Capital Minority
Japan System Techniques Corporation Minority
To view Regenesome’s complete investors history, request access »

Regenesome Acquisitions (1)

Regenesome’s most recent deal was a Merger/Acquisition with Gindo. The deal was made on 15-Jan-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Gindo 15-Jan-2026 Merger/Acquisition Food Products
To view Regenesome’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Regenesome FAQs

  • When was Regenesome founded?

    Regenesome was founded in 2024.

  • Where is Regenesome headquartered?

    Regenesome is headquartered in Tokyo, Japan.

  • What industry is Regenesome in?

    Regenesome’s primary industry is Other Healthcare Technology Systems.

  • Is Regenesome a private or public company?

    Regenesome is a Private company.

  • What is Regenesome’s current revenue?

    The current revenue for Regenesome is .

  • How much funding has Regenesome raised over time?

    Regenesome has raised $342K.

  • Who are Regenesome’s investors?

    Leave a Nest Capital and Japan System Techniques have invested in Regenesome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process